Canadian Institutes of Health Research
Français Contact UsHelpSearchCanada Site
CIHR HomeAbout CIHRWhat's NewFunding OpportunitiesFunding Decisions
CIHR | IRSC
About CIHR
CIHR Institutes
Funding Health Research
Funding News and Developments
Archive
Funding Opportunities
How to Apply for Funding
CIHR Funding Policy
Peer Review
Funding Decisions
Funding Related Databases
Training Opportunities
ResearchNet
Knowledge Translation and Commercialization
Partnerships
Major Strategic Initiatives
International Cooperation
Ethics
News and Media
Publications
 

CIHR Policy in Development - Access to Products of Research

(2006-04-03) CIHR's strategic plan, "Blueprint for Health Research and Innovation", states that CIHR's vision is to position Canada as a world leader in the creation and use of knowledge for health benefits. In an effort to achieve this long-term strategic outcome, CIHR is initiating a process to develop a research policy that will promote access to the knowledge and resources generated from CIHR-funded research. Currently, CIHR encourages recipients of research support to make the results of all research publicly available. However, CIHR does not have a formal policy governing access to the products of CIHR-funded research, including physical products, research data and published results.

The aim is to establish a policy that will both help researchers gain access to the products of research and support CIHR's efforts in facilitating the translation and use of knowledge, while taking into account ethical and legal considerations. Furthermore, as a recipient of public funds there is an obligation to Canadians to ensure that the results and products of research supported by CIHR are disseminated as widely as possible so that all parties benefit from these research outcomes.

The policy governing access to the products of research has been separated into three broad categories:

  1. physical products of research (i.e., cell lines, DNA libraries, PCR primers);
  2. structural and functional data typically deposited in public databases (i.e., genomic data, DNA sequences, protein sequences);
  3. peer-reviewed published results.

CIHR has invited a number of Canadian health researchers to serve on an Advisory Committee, which will guide the development and implementation of this policy. In the near future, CIHR will be launching an initial online survey, with a series of prompts and questions regarding the general scope and content of a proposed policy. Feedback from the broad health research community will be carefully considered by the Advisory Committee during policy development. We welcome comments from the full range of stakeholders including other government departments and research agencies, health research societies, health charities, and industry partners. Once a detailed draft policy has been prepared, it will be posted on our web site for a second round of public consultations. Please visit CIHR's web site in the coming weeks to see more information about this initiative.

If you have any questions related to CIHR's plans to develop a policy concerning Access to the Products of Research, please contact Geoff Hynes, Research Officer, ghynes@cihr-irsc.gc.ca, (613) 952-8965.


Created: 2006-04-03
Modified: 2006-04-03
Reviewed: 2006-04-03
Print